Multiple pathways of recombination define cellular responses to cisplatin

Chemistry and Biology

Volumn 7, Issue 1, 2000, Pages 39-50

  Zdraveski, Zoran Z ^a   Mello, Jill A ^a   Marinus, Martin G ^b   Essigmann, John M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cisplatin; DNA repair; Double strand breaks; Mitomycin C; Recombination

Indexed keywords

BACTERIAL MUTANT; CELL DIVISION; CELL SURVIVAL; CISPLATIN; CROSS LINKING; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; ESCHERICHIA COLI; GENETIC STRAIN; ISOMERISM; NUCLEOTIDE EXCISION REPAIR; TUMOR CELL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0034010037     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00064-8     Document Type: Article

References (65)

1. Friedberg E.C., Walker G.C., Siede W. DNA Repair and Mutagenesis. 1995;American Society for Microbiology Press, Washington, DC.
2. Kuzminov A. Recombinational Repair of DNA Damage. 1996;R.G. Landes Company, Austin.
3. Cox M.M. A broadening view of recombinational DNA repair in bacteria. Genes Cell. 3:1998;65-78.
4. Loehrer P.J., Einhorn L.H. Cisplatin. Ann. Int. Med. 100:1984;704-713.
5. Eastman A. Characterization of the adducts produced in DNA be cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry. 22:1983;3927-3933.
6. Fichtinger-Schepman A.M.J., van der Veer J.L., den Hartog J.H., Lohman P.H., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 24:1985;707-713.
7. Bruhn S.L., Toney J.H., Lippard S.J. Biological processing of DNA modified by platinum compounds. Prog. Inorg. Chem. 38:1990;477-516.
8. Mello J.A., Trimmer E.E., Kartalou M., Essigmann J.M. Conflicting roles of mismatch repair and nucleotide excision repair in cellular susceptibility to anticancer drugs. Nucleic Acids Mol. Biol. 12:1998;249-274.
9. Sarachek A., Henderson L., Wilkens W.E. Evaluation of the genotoxic spectrum of cisplatin for Candida albicans. Microbios. 72:1992;183-201.
10. Vogel E.W., Zijlstra J.A. Mechanistic and methodological aspects of chemically-induced somatic mutation and recombination in Drosophila melanogaster. Mutat. Res. 182:1987;243-264.
11. Hanneman W.H., Legare M.E., Sweeney S., Schimenti J.C. Cisplatin increases meiotic crossing-over in mice. Proc. Natl Acad. Sci. USA. 94:1997;8681-8685.
12. Beck D.J., Brubaker R.R. Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair-deficient mutants of Escherichia coli. J. Bacteriol. 116:1973;1247-1252.
13. Alazard R., Germanier M., Johnson N.P. Mechanism of toxicity of platinum (II) compounds in repair-deficient strains of Escherichia coli. Mutat. Res. 93:1982;327-337.
14. Jarosik G.P., Beck D.J. The effects of cis-platinum (II)diamminodichloride, UV light and N-methyl-N′-nitro-N-nitrosoguanidine on Escherichia coli:plasmid mediated resistance to mutagens. Chem. Biol. Interact. 51:1984;247-259.
15. Hannan M.A., Zimmer S.G., Hazle J. Mechanisms of cisplatin (cis-diamminodichloroplatinum II)-induced cytotoxicity and genotoxicity in yeast. Mutat. Res. 127:1984;23-30.
16. McA'Nulty M.M., Lippard S.J. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat. Res. 362:1996;75-86.
17. Perego P., Zunino F., Carenini N., Giuliani F., Spinelli S., Howell S.B. Sensitivity to cisplatin and platinum-containing compounds of Schizosaccharomyces pombe rad mutants. Mol. Pharmacol. 54:1998;213-219.
18. Rupp W.D., Howard-Flanders P. Discontinuities in the DNA synthesized in an excision-defective strain of Escherichia coli following ultraviolet irradiation. J. Mol. Biol. 31:1968;291-304.
19. Tseng Y.C., Hung J.L., Wang T.C. Involvement of RecF pathway recombination genes in postreplication repair in UV-irradiated Escherichia coli cells. Mutat. Res. 315:1994;1-9.
20. Umezu K., Chi N.W., Kolodner R.D. Biochemical interaction of the Escherichia coli RecF, RecO, and RecR proteins with RecA protein and single-stranded DNA binding protein. Proc. Natl Acad. Sci. USA. 90:1993;3875-3879.
21. Webb B.L., Cox M.M., Inman R.B. Recombinational DNA repair: the RecF and RecR proteins limit the extension of RecA filaments beyond single-strand DNA gaps. Cell. 91:1997;347-356.
22. Courcelle J., Carswell-Crumpton C., Hanawalt P.C. recF and recR are required for the resumption of replication at DNA replication forks in Escherichia coli. Proc. Natl Acad. Sci. USA. 94:1997;3714-3719.
23. Sargentini N.J., Smith K.C. Quantitation of the involvement of the recA, recB, recC, recF, recJ, recN, lexA, radA, radB, uvrD, and umuC genes in the repair of X-ray induced DNA double-strand breaks in Escherichia coli. Radiat. Res. 107:1986;58-72.
24. Taylor A.F., Schultz D.W., Ponticelli A.S., Smith G.R. RecBC enzyme nicking at Chi sites during DNA unwinding: location and orientation-dependence of the cutting. Cell. 41:1985;153-163.
25. Anderson D.G., Kowalczykowski S.C. The translocating RecBCD enzyme stimulates recombination by directing RecA protein onto ssDNA in a chi-regulated manner. Cell. 90:1997;77-86.
26. Bianco P.R., Tracy R.B., Kowalczykowski S.C. DNA strand exchange proteins: a biochemical and physical comparison. Front. Biosci. 3:1998;D570-D603.
27. Eggleston A.K., West S.C. Recombination initiation: easy as A, B, C, D. chi? Curr. Biol. 7:1997;R745-R749.
28. Wang T.C., Smith K.C. Postreplicational formation and repair of DNA double-strand breaks in UV-irradiated Escherichia coli uvrB cells. Mutat. Res. 165:1986;39-44.
29. Chaudhury A.M., Smith G.R. A new class of Escherichia coli recBC mutants: implications for the role of RecBC enzyme in homologous recombination. Proc. Natl Acad. Sci. USA. 81:1984;7850-7854.
30. Parsons C.A., Tsaneva I., Lloyd R.G., West S.C. Interaction of Escherichia coli RuvA and RuvB proteins with synthetic Holliday junctions. Proc. Natl Acad. Sci. USA. 89:1992;5452-5456.
31. Lloyd R.G., Sharples G.J. Dissociation of synthetic Holliday junctions by Escherichia coli RecG protein. EMBO J. 12:1993;17-22.
32. Eggleston A.K., Mitchell A.H., West S.C. In vitro reconstitution of the late steps of genetic recombination in Escherichia coli. Cell. 89:1997;607-617.
33. Sharples G.J., Benson F.E., Illing G.T., Lloyd R.G. Molecular and functional analysis of the ruv region of Escherichia coli K-12 reveals three genes involved in DNA repair and recombination. Mol. Gen. Genet. 221:1990;219-226.
34. Lloyd R.G., Buckman C. Genetic analysis of the recG locus of Escherichia coli K-12 and of its role in recombination and DNA repair. J. Bacteriol. 173:1991;1004-1011.
35. Zamble D.B., Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem. Sci. 20:1995;435-439.
36. Husain I., Chaney S.G., Sancar A. Repair of cis-platinum-DNA adducts by ABC exinuclease in vivo and in vitro. J. Bacteriol. 163:1985;817-823.
37. Eastman A., Jennerwein M.M., Nagel D.L. Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II). Chem. Biol. Interact. 67:1988;71-80.
38. Brabec V., Leng M. DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl Acad. Sci. USA. 90:1993;5345-5349.
39. Tomasz M. Mitomycin C: small, fast and deadly (but very selective). Chem. Biol. 2:1995;575-579.
40. Pascoe J.M., Roberts J.J. Interactions between mammalian cell DNA and inorganic platinum compounds-I. Biochem. Pharmacol. 23:1974;1345-1357.
41. Zwelling L.A., Anderson T., Kohn K.W. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 39:1979;365-369.
42. Seigneur M., Bidnenko V., Ehrlich S.D., Michel B. RuvAB acts at arrested replication forks. Cell. 95:1998;419-430.
43. Chu G. Cellular responses to cisplatin. J. Biol. Chem. 269:1994;787-790.
44. Hoffmann J.S., Locker D., Villani G., Leng M. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts. J. Mol. Biol. 270:1997;539-543.
45. Murchie A.I.H., Lilley D.M.J. T4 endonuclease VII cleaves DNA containing a cisplatin adduct. J. Mol. Biol. 233:1993;77-85.
46. Duckett D.R., Modrich P.et al. Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl Acad. Sci. USA. 93:1996;6443-6447.
47. Mello J.A., Acharya S., Fishel R., Essigmann J.M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3:1996;579-589.
48. Yamada M., O'Regan E., Brown R., Karran P. Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. Nucleic Acids Res. 25:1997;491-495.
49. Villani G., Cazaux C., Pillaire M.J., Boehmer P. Effects of a single intrastrand d(GpG) platinum adduct on the strand separating activity of the Escherichia coli proteins RecB and RecA. FEBS Lett. 333:1993;89-95.
50. Bosl G.J., Motzer R.J. Testicular germ-cell cancer. New Engl. J. Med. 337:1997;242-253.
51. Adler I.D., el-Tarras A. Clastogenic effects of cis-diamminedichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice. Mutat. Res. 211:1989;131-137.
52. Adler I.D., el-Tarras A. Clastogenic effects of cis-diamminedichloroplatinum. II. Induction of chromosomal aberrations in primary spermatocytes and spermatogonial stem cells of mice. Mutat. Res. 243:1990;173-178.
53. Fink D., Howell S.B.et al. Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues. Br. J. Cancer. 76:1997;890-893.
54. Her C., Doggett N.A. Cloning, structural characterization, and chromosomal localization of the human orthologue of Saccharomyces cerevisiae MSH5 gene. Genomics. 52:1998;50-61.
55. Winand N.J., Panzer J.A., Kolodner R.D. Cloning and characterization of the human and Caenorhabditis elegans homologs of the Saccharomyces cerevisiae MSH5 gene. Genomics. 53:1998;69-80.
56. Paquis-Flucklinger V., Santucci-Darmanin S., Paul R., Saunieres A., Turc-Carel C., Desnuelle C. Cloning and expression analysis of a meiosis-specific MutS homolog: the human MSH4 gene. Genomics. 44:1997;188-194.
57. Karran P., Bignami M. Drug-related killings: a case of mistaken identity. Chem. Biol. 3:1996;875-879.
58. Durant S.T., Brown R.et al. Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. Curr. Biol. 9:1999;51-54.
59. Gong J.G., Wang J.Y.et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:1999;806-809.
60. Masters J.R.W., Osborne E.J., Walker M.C., Parris C.N. Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs. Int. J. Cancer. 53:1993;340-346.
61. Miller J.H. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. 1992;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY.
62. Konrad E.B. Method for the isolation of Escherichia coli mutants with enhanced recombination between chromosomal duplications. J. Bacteriol. 130:1977;167-172.
63. Davis B.D., Mingioli E.S. Mutants of Escherichia coli requiring methionine or vitamin B12. J. Bacteriol. 60:1951;17.
64. West S.C., Cassuto E., Howard-Flanders P. Mechanism of Escherichia coli RecA protein directed strand exchanges in post-replication repair of DNA. Nature. 294:1981;659-662.
65. Szostak J.W., Orr-Weaver T.L., Rothstein R.J., Stahl F.W. The double-strand-break repair model for recombination. Cell. 33:1983;25-35.